ASPIRUS ONTONAGON HOSPITAL — History
CCN 231309 | 3-year financial timeline | COVID resilience: 17/100
🛡️ Public data only — no PHI permitted on this instance.
$10M
Latest Revenue (FY2022)
-12.7%
Revenue CAGR (3yr)
-30.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $13M | $12M | $10M | -16.5% | -12.7% |
| Operating Expenses | $15M | $14M | $13M | -8.0% | -6.3% |
| Operating Margin | -13.3% | -18.6% | -30.6% | -64.9% | +0.0% |
| Net Income | $-2M | $-2M | $-3M | -37.7% | +0.0% |
| Licensed Beds | 18 | 18 | 18 | +0.0% | +0.0% |
| Total Patient Days | 512 | 931 | 679 | -27.1% | +15.2% |
| Medicare Day % | 56% | 58% | 52% | -11.0% | -4.0% |
| Medicaid Day % | nan% | 0% | 1% | +37.1% | +nan% |
COVID Impact & Recovery
Resilience Score: 17/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -23.8% ($13M → $10M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-12.7%
This Hospital
+7.6%
State Avg
Latest Margin
-30.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $8M | -39.2% |
| FY2024 (proj) | $7M | -47.9% |
| FY2025 (proj) | $5M | -56.5% |